You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
龍津藥業(002750.SZ):子公司擬與關聯方中創晟瑞共設龍津睿達
格隆匯 09-01 19:32

格隆匯 9 月 1日丨龍津藥業(002750.SZ)公佈,公司全資子公司雲南龍津梵天生物科技有限責任公司(“龍津梵天”)擬與關聯方雲南中創晟瑞數據有限公司(“中創晟瑞”)共同投資新設立控股企業“雲南龍津睿達生物醫藥合夥企業(有限合夥)”(暫定名,“龍津睿達”),註冊資本2590萬元人民幣,其中龍津梵天以自有資金出資2520萬元,佔出資總額的97.2973%,雙方將在昆明市簽署《合夥協議》。

雲南龍津睿達生物醫藥合夥企業(有限合夥)經營範圍:醫藥信息諮詢服務(不含診療),普通貨物運道路運輸代理,物流信息諮詢,醫療技術研發、醫療科技專業領域內的技術諮詢,技術轉讓;電子商務平台技術研發,計算機軟硬件研發,信息系統集成服務,數據處理及儲存服務,互聯網技術服務(除電信增值業務);商務信息諮詢;企業管理諮詢;提供企業營銷策劃、文化、藝術活動策劃;產品包裝設計;商務文印服務;(依法須經批准的項目,經相關部門批准後方可開展經營活動)

引入中創晟瑞作為合作伙伴,有利於將公司高級管理人員及營銷人員利益與公司利益綁定,共享收益、共擔風險,形成良性有效的激勵機制。

工業和商業協同發展是中國醫藥行業未來發展趨勢之一,龍津睿達設立後,將盡快與合作方共同投資設立昆明龍津藥業銷售有限公司,為進一步聚焦公司主營業務發展,逐步完善佈局公司業務網絡建設提供支持。此次設立合資公司所需資金為公司自有資金,且前期投入較少,預計不會對公司本年度財務及經營狀況產生重大影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account